Ruizhao Qi
发表
Zhenyu Zhu,
Shaogeng Zhang,
Keming Zhang,
2013
.
J. Rui,
R. Zhou,
Hua Yang,
2010,
Journal of surgical oncology.
Tian-shu Ren,
Yi-da Yang,
Jinqiu Yuan,
2022,
Therapeutic advances in gastroenterology.
Xiao-dong Guo,
Shaogeng Zhang,
Ling-xiang Yu,
2014,
OncoTargets and therapy.
Jilly F. Evans,
Z. Zou,
A. Floreani,
2016,
Autoimmunity reviews.
Ruizhao Qi,
Huixing Li,
Xianjie Shi,
2020,
Medical science monitor : international medical journal of experimental and clinical research.
X. Qi,
Xiaoning Zhu,
Jing Wang,
2017,
Oncotarget.
Z. Mao,
Li Li,
Ming Lin,
2013,
Journal of gastroenterology and hepatology.
Xiao-dong Guo,
Zhiwei Li,
Yinying Lu,
2017,
Biochemical and biophysical research communications.
Zhaohai Wang,
Keming Zhang,
Yilu Zhang,
2012,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
X. Qi,
Weijie Zhang,
Chuan Liu,
2020,
BMJ Open.
Xin-Li Jin,
Ruizhao Qi,
Haida Shi,
2019,
Annals of hepatology.
Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo
Q. Ding,
R. Safadi,
Yinying Lu,
2020,
Cell Death & Disease.
X. Qi,
Xiaoning Zhu,
Jing Wang,
2016,
Oncotarget.
Jitao Wang,
Baijun Sun,
Zhiwei Li,
2017,
Oncology reports.
Jie Tian,
Xianghui Qi,
Chuan Liu,
2019,
Radiology.
Zaiyi Liu,
Jie Tian,
Jiahong Dong,
2018,
EBioMedicine.
Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo
Q. Ding,
R. Safadi,
Yinying Lu,
2020,
Cell Death & Disease.
Xiao-dong Guo,
Shaogeng Zhang,
Ling-xiang Yu,
2014,
OncoTargets and therapy.